In the blink of an eye, Aphria (APHA) dipped to the lows $3s. The Canadian cannabis company remains the prime investable stock in the sector with the best combination of facilities, revenues and cash on the balance sheet. Despite all the positives, the stock is down nearly 70% from the highs this time last year providing the chance that investors shouldn’t pass up.Low InventoryPossibly the best part of the Aphria story was the company not wildly build facilities in 2019. In the process, the company didn’t build up a large inventory before the Canadian cannabis market was fully ready for sales.The company ended the November quarter with only C$152 million in inventories. Aphria started the fiscal year with just C$92 million in inventory. Of these inventories, nearly C$37 million is related to the distribution business and another C$20 million are unrelated to cannabis. The company even had to purchase inventories in...
Coronavirus is probably the 1 concern in investors' minds right now. It should be. We estimate that COVID-19 will kill around 5 million people worldwide and there is a 3.3% probability that Donald Trump will die from the new coronavirus (see the details). So, how do we invest in this environment? We watch corporate insiders […]...
Dr. James Hamblin, MD of The Atlantic explains that the coronavirus might affect many people in the U.S., but if it's over a long, extended period, it might not overwhelm resources as patients come in waves....
Coronavirus is probably the 1 concern in investors' minds right now. It should be. We estimate that COVID-19 will kill around 5 million people worldwide and there is a 3.3% probability that Donald Trump will die from the new coronavirus (see the details). So, how do we invest in this environment? Our extensive research has […]...